Skip to content
Thursday, March 30, 2023
Latest:
  • European Commission Approves mAbxience’s Bevacizumab For The Treatment Of Certain Types Of Cancer
  • Enerkon Solar International (ENKS) Names New Board and Scientific Committee Members and Announces New FARA Filing in Support of Commercial Aspirations
  • Delic’s Acquisition Target, Complex Biotech Discovery Ventures Ltd., Receives First Research Orders Through Online Payment Platform
  • FSD Pharma Inc. Management Wasting Company Money by Seeking to Further Delay Shareholder Meeting
  • PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin
Biotech Market Reporter

Biotech Market Reporter

Know First, Act First

  • Cannabis
  • General
  • Covid
  • Financing
  • Global
  • Trending

General

BIOTCHNO General 

FSD Pharma Inc. Management Wasting Company Money by Seeking to Further Delay Shareholder Meeting

March 30, 2021April 8, 2021 Raza

  Canada NewsWire TORONTO , April 5, 2021 /CNW/ – On Tuesday, March 30, 2021 , Anthony Durkacz , a

Read more
BIOTCHNO General 

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

March 23, 2021April 8, 2021 Raza

  Canada NewsWire OXFORD, Ohio and COCONUT CREEK, Fla. , March 23, 2021 /CNW/ – PsyBio Therapeutics Corp. (TSXV: PSYB)

Read more
BIOTCHNO General 

FACT, Inc. Announces Patricia Trompeter as CEO

March 22, 2021June 7, 2021 Raza

Toronto, Ontario–(Newsfile Corp. – March 22, 2021) – FACT, Inc. (OTC Pink: FCTI) (the “Company” or “FACT“) a global leader

Read more
Cannabis General 

Harvest Health & Recreation Inc. To Hold Fourth Quarter and Full Year 2020 Earnings Conference Call

March 12, 2021April 14, 2021 Raza

  Harvest Health & Recreation Inc. To Hold Fourth Quarter and Full Year 2020 Earnings Conference Call on March 30,

Read more
BIOTCHNO General 

MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company’s Clinical Research

March 3, 2021July 26, 2021 Raza

Canada NewsWire The Company expects to have ibogaine manufactured and in use for research by Q4. VANCOUVER, BC , March

Read more
BIOTCHNO General 

Glucose Health, Inc. – Amazon Revenues Exceed $50,000 Per Month

March 1, 2021July 19, 2021 Raza

Bentonville, Arkansas–(Newsfile Corp. – March 1, 2021) – GLUCODOWN® (OTC Pink: GLUC) revenues at Amazon for the month of February 2021

Read more
BIOTCHNO General 

Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones

February 26, 2021May 17, 2021 Raza

ADELAIDE, AU, Feb 26, 2021 – (ACN Newswire) – The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific

Read more
BIOTCHNO General 

Arbitrator Rules for Neptune Wellness Solutions Inc. in Dispute With Azpa Pharmaceuticals Pty. Ltd.

February 18, 2021April 15, 2021 Bachittar

Canada NewsWire LAVAL, QC, Feb. 18, 2021/CNW/ –Neptune Wellness Solutions Inc.(“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT), a diversified

Read more
BIOTCHNO General 

Neptune Wellness Solutions Inc. Announces Termination of “At-The-Market” Offering

February 17, 2021April 15, 2021 Bachittar

  Canada NewsWire LAVAL, QC, Feb. 17, 2021/CNW Telbec/ – Neptune Wellness Solutions, Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX:

Read more
BIOTCHNO General 

LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Demonstrated Superior Progression-Free Survival (PFS) and Overall Survival (OS) Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

February 15, 2021May 24, 2021 Bachittar

LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Demonstrated Superior Progression-Free Survival (PFS) and Overall Survival (OS) Versus Sunitinib as First-Line Treatment for

Read more
  • ← Previous

Trending

SQI Diagnostics Announces New Corporate Website
BIOTCHNO Trending 

SQI Diagnostics Announces New Corporate Website

February 18, 2021April 15, 2021 Bachittar

Canada NewsWire New Website Provides Essential Information on Company’s Strategic Initiative TORONTO, Feb. 18, 2021/CNW/ – SQI Diagnostics Inc. (the

Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
BIOTCHNO Trending 

Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021

February 16, 2021April 15, 2021 Bachittar
Mountain Valley MD Holdings Announces Application for OTCQB Listing in U.S.
BIOTCHNO Trending 

Mountain Valley MD Holdings Announces Application for OTCQB Listing in U.S.

February 11, 2021April 15, 2021 vanessa
Eupraxia Pharmaceuticals Inc. Announces Filing of Preliminary Prospectus for Proposed Initial Public Offering
BIOTCHNO Trending 

Eupraxia Pharmaceuticals Inc. Announces Filing of Preliminary Prospectus for Proposed Initial Public Offering

February 11, 2021April 15, 2021 Bachittar
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
5826 New Territory Blvd. Unit #2144 Sugar Land, TX 77479